JAK Inhibition as a Therapeutic Strategy for Inflammatory Bowel Disease.

Current Drug Metabolism
Fabio Salvatore Macaluso, Iago Rodríguez-Lago

Abstract

Inflammatory bowel disease, including both Crohn's disease and ulcerative colitis, are two chronic and progressive disorders affecting the gastrointestinal tract. Research on the molecular mechanisms of both diseases has led to the introduction of targeted therapies which are able to selectively block the key inflammatory mediators. Here, we discuss the current evidence about the mechanism of action with an up to date review of the efficacy and safety of Janus kinase inhibitors in inflammatory bowel disease. Multiple small molecule drugs have been evaluated for their use in both ulcerative colitis and Crohn's disease. Janus kinase inhibitors represent the most important family of these drugs, as their particular mechanism of action enables a simultaneous and effective blockade of multiple cytokines involved in the pathogenesis of the disease. Janus kinase inhibitors represent a promising therapeutic strategy, especially in ulcerative colitis. More data are still necessary regarding its efficacy and safety in clinical practice.

References

May 23, 1998·Annual Review of Immunology·W J Leonard, J J O'Shea
Jan 31, 2004·Current Opinion in Allergy and Clinical Immunology·Sigrun R HofmannJohn J O'Shea
Jan 9, 2007·Molecular Immunology·Lynda A O'SullivanAlister C Ward
Mar 18, 2009·Immunological Reviews·Kamran GhoreschiJohn J O'Shea
Sep 24, 2009·Current Rheumatology Reports·Melissa MaversHarris Perlman
Nov 20, 2009·The New England Journal of Medicine·Clara Abraham, Judy H Cho
Mar 4, 2011·Alimentary Pharmacology & Therapeutics·S Ben-Horin, Y Chowers
Aug 17, 2012·The New England Journal of Medicine·William J SandbornUNKNOWN Study A3921063 Investigators
Jan 11, 2013·The New England Journal of Medicine·John J O'SheaLouis M Staudt
Jan 15, 2014·Journal of Medicinal Chemistry·James D ClarkJean-Baptiste Telliez
Feb 1, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·William J SandbornUNKNOWN Study A3921043 Investigators
Jun 20, 2014·Arthritis & Rheumatology·Kevin L WinthropRichard Riese
Jan 13, 2015·Inflammatory Bowel Diseases·Tugrul Purnak, Osman Yuksel
Jun 26, 2015·Human Vaccines & Immunotherapeutics·Adrian G Murphy, Lei Zheng
Jan 30, 2016·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Alessandro ArmuzziUNKNOWN GIVI (Gruppo Italiano su Vedolizumab nelle IBD) Group
Jun 11, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Megan E B ClowseAmy Marren
Dec 14, 2016·The New England Journal of Medicine·Brian G FeaganUNKNOWN UNITI–IM-UNITI Study Group
Feb 7, 2017·Expert Review of Clinical Immunology·Pablo OliveraLaurent Peyrin-Biroulet
Mar 7, 2017·The Journal of Infection·Giovanni MazzolaAmbrogio Orlando
May 4, 2017·The New England Journal of Medicine·William J SandbornUNKNOWN OCTAVE Induction 1, OCTAVE Induction 2, and OCTAVE Sustain Investigators
Apr 16, 2018·Gastroenterology·Julien KirchgesnerRosemary Dray-Spira
Jun 1, 2018·Inflammatory Bowel Diseases·Kevin L WinthropChinyu Su
Jun 20, 2018·Journal of Crohn's & Colitis·Bruce E SandsUNKNOWN Peficitinib-UC Study Group
Jul 18, 2018·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Stephen HanauerChinyu Su
Jul 22, 2018·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Laurent Beaugerie, Julien Kirchgesner
Sep 13, 2018·The New England Journal of Medicine·Kim PappSubhashis Banerjee
Sep 27, 2018·Nature Reviews. Immunology·Simon A Jones, Brendan J Jenkins
Oct 5, 2018·Expert Review of Clinical Immunology·Agnès Fernández-ClotetJulián Panés
Nov 27, 2018·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·William J SandbornGary Chan
Dec 21, 2018·Expert Opinion on Biological Therapy·Fabio Salvatore MacalusoMario Cottone
Dec 21, 2018·Autoimmunity Reviews·Laurent Peyrin-BirouletAjay Nirula
Feb 15, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·K Phan, D F Sebaratnam

❮ Previous
Next ❯

Citations

Jul 3, 2020·Current Drug Metabolism·Radislav NakovGianluca Ianiro
May 21, 2021·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Fabio Salvatore MacalusoAmbrogio Orlando

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Gastroenterology Clinics of North America
Brigid S BolandJohn T Chang
Current Pharmaceutical Design
Agnès Fernández-ClotetJulián Panés
Journal of Crohn's & Colitis
Pavine L C Lefevre, Niels Vande Casteele
© 2021 Meta ULC. All rights reserved